The response; of course...nothing to offer of anything to us minions!!!!

Thank you for your question, and I apologize for the delayed response. We are excited about the potential of ZEN-3694 to benefit patients across the multiple oncology indications currently under clinical investigation. As you are likely aware, many of the ongoing trials are investigator-led studies and/or are being performed in collaboration with other parties, meaning that Zenith is not solely responsible for managing these trials. As a result, I do not specific timelines for when we can expect clinical data to be publicly available from our ongoing trials. However, I want to assure you that as data becomes available publicly, we will do our best to communicate any significant findings of these trials with our stakeholders. 

Thank you for your patience. 

Best regards, 

Chris